Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart
- PMID: 19295307
- PMCID: PMC2866004
- DOI: 10.1097/TP.0b013e31819609d9
Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart
Abstract
Background: Mesenchymal stem cells hold promise for cardiovascular regenerative therapy. Derivation of these cells from the adipose tissue might be easier compared with bone marrow. However, the in vivo fate and function of adipose stromal cells (ASC) in the infarcted heart has never been compared directly to bone marrow-derived mesenchymal cells (MSC).
Methods: ASC and MSC were isolated from transgenic FVB mice with a beta-actin promoter driving firefly luciferase and green fluorescent protein double fusion reporter gene, and they were characterized using flow cytometry, microscopy, bioluminescence imaging and luminometry. FVB mice (n=8 per group) underwent myocardial infarction followed by intramyocardial injection of 5x10(5) ASC, MSC, fibroblasts (Fibro, positive control), or saline (negative control). Cell survival was measured using bioluminescence imaging for 6 weeks and cardiac function was monitored by echocardiography and pressure-volume analysis. Ventricular morphology was assessed using histology.
Results: ASC and MSC were CD34(-), CD45(-), c-Kit(-), CD90(+), Sca-1(+), shared similar morphology and had a population doubling time of approximately 2 days. Cells expressed Fluc reporter genes in a number-dependent fashion as confirmed by luminometry. After cardiac transplantation, both cell types showed drastic donor cell death within 4 to 5 weeks. Furthermore, transplantation of either cell type was not capable of preserving ventricular function and dimensions, as confirmed by pressure-volume-loops and histology.
Conclusion: This is the first study comparing the in vivo behavior of both cell types in the infarcted heart. ASC and MSC do not tolerate well in the cardiac environment, resulting in acute donor cell death and a subsequent loss of cardiac function similar to control groups.
Figures
Similar articles
-
Comparison of different adult stem cell types for treatment of myocardial ischemia.Circulation. 2008 Sep 30;118(14 Suppl):S121-9. doi: 10.1161/CIRCULATIONAHA.107.759480. Circulation. 2008. PMID: 18824743 Free PMC article.
-
[Beneficial effects of liver X receptor agonist on adipose-derived mesenchymal stem cells transplantation in mice with myocardial infarction].Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Sep;40(9):723-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2012. PMID: 23141082 Chinese.
-
mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction.J Am Heart Assoc. 2019 Jan 8;8(1):e010157. doi: 10.1161/JAHA.118.010157. J Am Heart Assoc. 2019. PMID: 30616426 Free PMC article.
-
Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models.Stem Cell Rev Rep. 2014 Jun;10(3):389-98. doi: 10.1007/s12015-014-9502-7. Stem Cell Rev Rep. 2014. PMID: 24577790 Review.
-
Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.Stem Cells Dev. 2012 Sep 20;21(14):2724-52. doi: 10.1089/scd.2011.0722. Epub 2012 May 9. Stem Cells Dev. 2012. PMID: 22468918 Review.
Cited by
-
Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Physiol Rev. 2016 Jul;96(3):1127-68. doi: 10.1152/physrev.00019.2015. Physiol Rev. 2016. PMID: 27335447 Free PMC article. Review.
-
Nanoparticles and clinically applicable cell tracking.Br J Radiol. 2015 Oct;88(1054):20150375. doi: 10.1259/bjr.20150375. Epub 2015 Aug 7. Br J Radiol. 2015. PMID: 26248872 Free PMC article. Review.
-
Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap.Stem Cells Int. 2012;2012:175979. doi: 10.1155/2012/175979. Epub 2012 Jan 22. Stem Cells Int. 2012. PMID: 22315617 Free PMC article.
-
In vivo bioluminescence for tracking cell fate and function.Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H663-71. doi: 10.1152/ajpheart.00337.2011. Epub 2011 Jun 10. Am J Physiol Heart Circ Physiol. 2011. PMID: 21666118 Free PMC article. Review.
-
Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Staphylococcal Enterotoxin A-Induced Toxic Shock.Infect Immun. 2015 Sep;83(9):3490-6. doi: 10.1128/IAI.00730-15. Epub 2015 Jun 22. Infect Immun. 2015. PMID: 26099581 Free PMC article.
References
-
- Rosamond W, Flegal K, Friday G, et al. Heart Disease and Stroke Statistics--2007 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 - PubMed
-
- Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701. - PubMed
-
- Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428(6983):668. - PubMed
-
- Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355(12):1199. - PubMed
-
- Schrepfer S, Deuse T, Lange C, et al. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. Stem Cells Dev. 2007;16(1):105. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous